The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis

Background: Acute kidney injury (AKI) may increase the risk of chronic kidney disease (CKD), development of end-stage renal disease (ESRD), and mortality. However, the impact of exposure to angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker (ACEi/ARB) in patients experiencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Yi, Tsai, I-Jung, Pan, Heng-Chih, Liao, Hung-Wei, Neyra, Javier A., Wu, Vin-Cent, Chueh, Jeff S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329451/
https://www.ncbi.nlm.nih.gov/pubmed/34354583
http://dx.doi.org/10.3389/fphar.2021.665250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329451/
https://www.ncbi.nlm.nih.gov/pubmed/34354583
http://dx.doi.org/10.3389/fphar.2021.665250

Ejemplares similares